Tenormin and Hepatitis fulminant - a phase IV clinical study of FDA data

Summary:

Hepatitis fulminant is reported as a side effect among people who take Tenormin (atenolol), especially for people who are male, 60+ old, have been taking the drug for 1 - 6 months also take Plavix, and have Acute coronary syndrome.

The phase IV clinical study analyzes which people have Hepatitis fulminant when taking Tenormin. It is created by eHealthMe based on reports of 20,083 people who have side effects when taking Tenormin from the FDA, and is updated regularly.

What is Tenormin?

Tenormin has active ingredients of atenolol. It is often used in high blood pressure. eHealthMe is studying from 20,474 Tenormin users. Check the latest studies of Tenormin.

What is Hepatitis fulminant?

Hepatitis fulminant (life-threatening condition defined by significantly impaired liver function) is found to be associated with 450 drugs and 677 conditions by eHealthMe. Check the latest studies of Hepatitis fulminant.

On Jul, 18, 2026

20,083 people reported to have side effects when taking Tenormin.
Among them, 20 people (0.1%) have Hepatitis fulminant.

Could Tenormin cause Hepatitis fulminant?

Among these 20 people:

How long have people been on Tenormin when they have Hepatitis fulminant? *

What is the gender of people who have Hepatitis fulminant when taking Tenormin? *

female: 50 %
male: 50 %

What is the age of people who have Hepatitis fulminant when taking Tenormin? *

What are other drugs people take besides Tenormin? *

What are other side effects people have besides Hepatitis fulminant? *

Consciousness - Decreased: 5 people, 25.00%
Hepatic Encephalopathy (spectrum of neuropsychiatric abnormalities in patients with liver failure): 5 people, 25.00%
Large Intestine Perforation (hole in large intestine): 5 people, 25.00%
Hepatic Necrosis (large portions of liver die off due to severe liver disease): 4 people, 20.00%
Weakness: 4 people, 20.00%
Multi-Organ Failure (multisystem organ failure): 3 people, 15.00%
Rhabdomyolysis (a condition in which damaged skeletal muscle tissue breaks down): 3 people, 15.00%
Hepatic Failure (liver failure): 3 people, 15.00%
Ascites (accumulation of fluid in the abdominal cavity): 2 people, 10.00%
Brain Oedema (excess accumulation of fluid in the intracellular or extracellular spaces of the brain): 2 people, 10.00%

What are the existing conditions these people have? *

Myocardial Ischaemia (the blood flow through one or more of the blood vessels that lead to heart (coronary arteries) is decreased): 2 people, 10.00%
Acute Coronary Syndrome (acute chest pain and other symptoms that happen because the heart does not get blood): 2 people, 10.00%
Urinary Incontinence (inability to control the flow of urine and involuntary urination): 1 person, 5.00%
Type 2 Diabetes: 1 person, 5.00%
T-Cell Lymphoma (a blood cell cancer): 1 person, 5.00%
Schizophrenia (a mental disorder characterized by a breakdown of thought processes): 1 person, 5.00%
Hyperlipidaemia (presence of excess lipids in the blood): 1 person, 5.00%
Essential Hypertension (primary hypertension): 1 person, 5.00%
Diabetes: 1 person, 5.00%
Bronchitis Acute (acute inflammation of the mucous membrane in the bronchial tubes): 1 person, 5.00%

* Approximation only. Some reports may have incomplete information.

Do you take Tenormin and have Hepatitis fulminant?

- Check whether Hepatitis fulminant is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Tenormin:

Tenormin (20,474 reports)

Browse all side effects of Tenormin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Hepatitis fulminant:

Hepatitis fulminant (450 drugs)

Browse all the conditions that are associated with Hepatitis fulminant:

Hepatitis fulminant (677 conditions)

Related publications that referenced our studies

Gupta MC, Khanna J, Mathur R, Mittal N, "Lamotrigine-induced fulminant hepatic failure: an unusual presentation", IMSEAR, 2015 Jan .
Gupta MC, Khanna J, Mathur R, Mittal N, "Lamotrigine-induced fulminant hepatic failure: an unusual presentation", IMSEAR, 2015 Jan .

How the study uses the data?

The study uses data from the FDA. It is based on atenolol (the active ingredients of Tenormin) and Tenormin (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.